Nightingale Health Oyj Overview
Pro stress-test →Nightingale Health is a Finnish health technology company that has developed advanced diagnostic tools detecting disease risks from a single blood sample. Operating across Finland, UK, Europe, US, and international markets, the company leverages proprietary biomarker analysis to enable preventative healthcare and empower individuals with comprehensive health insights.
Strategic Profile
Pro stress-test →The company positions itself at the intersection of personalized medicine and preventative healthcare, utilizing its proprietary Health Data Platform to detect risks for multiple chronic diseases. Nightingale connects healthcare providers with individuals seeking preventative services, operating through both in-person and remote health check models.
Competitive Landscape
Pro stress-test →Nightingale competes with GeneDx Holding, Truvian, and Lark in the health diagnostics and preventative healthcare space. The company differentiates through its multi-biomarker blood analysis platform and remote health check capabilities, though faces competitive pressure from established diagnostics companies and well-funded health tech startups.
Industry Context
Nightingale Health Oyj operates in Health Technology / Diagnostics.
Key facts
Founded: 2002 · Headquarters: Helsinki, Finland · Employees: 86 · Revenue: $5.1M · Market cap: $151M